Insyn2A: A Potential Drug Target and Biomarker (G642938)

Target Name: INSYN2A

NCBI ID: G642938

INSYN2A

Insyn2A: A Potential Drug Target and Biomarker

INSYN2A is a protein that is expressed in various tissues of the body, including the brain, heart, and liver. It is a member of the Insulin-like growth factor (IGF) family, which includes proteins that are involved in cell growth and survival. While INSYN2A is not well-studied, research has identified several potential functions for this protein. This article will explore the potential implications of INSYN2A as a drug target or biomarker.

Potential Functions as a Drug Target

INSYN2A has been shown to play a role in several cellular processes that are important for brain development and function. One of the most promising functions of INSYN2A is its role in the development and maintenance of neuronal stem cells. These stem cells are responsible for the formation and maintenance of the nervous system, and they are critical for the development of new neurons and the repair of damaged tissue.

INSYN2A has been shown to promote the self-renewal and survival of neuronal stem cells. This is important because these stem cells are often used to treat various neurological disorders, such as cancer, neurodegenerative diseases, and developmental disorders. By promoting the survival and self-renewal of neuronal stem cells, INSYN2A may have implications for the treatment of these disorders.

Another potential function of INSYN2A is its role in the regulation of cell death.INSYN2A has been shown to play a role in the production of programmed cell death (apoptosis), which is a natural process that helps remove damaged or dysfunctional cells from the body. This is important because cells that are no longer needed or are damaged can contribute to the development of various diseases, including cancer, neurodegenerative diseases, and developmental disorders.

Potential Use as a Biomarker

INSYN2A may also be used as a biomarker for certain diseases. As discussed above, INSYN2A is expressed in a variety of tissues and has been shown to play a role in the development and maintenance of neuronal stem cells. This suggests that it may be a useful biomarker for the treatment of conditions that affect these stem cells, such as cancer, neurodegenerative diseases, and developmental disorders.

In addition to its potential as a drug target, INSYN2A may also be used as a biomarker for certain diseases. For example, INSYN2A has been shown to be expressed in the brains of individuals with Alzheimer's disease, which is a neurodegenerative disorder that is characterized by the progressive loss of brain cells. This suggests that INSYN2A may be a useful biomarker for the diagnosis and treatment of Alzheimer's disease.

Conclusion

INSYN2A is a protein that has been shown to play a role in several cellular processes that are important for brain development and function. While more research is needed, the potential implications of INSYN2A as a drug target or biomarker are significant. As discussed above, INSYN2A has been shown to promote the self-renewal and survival of neuronal stem cells and to play a role in the regulation of cell death. Additionally, INSYN2A has been shown to be expressed in the brains of individuals with Alzheimer's disease, which suggests that it may be a useful biomarker for this disease.

Overall, while more research is needed, the potential implications of INSYN2A as a drug target or biomarker are promising. Further studies are needed to fully understand the functions of this protein and its potential as a therapeutic agent.

Protein Name: Inhibitory Synaptic Factor 2A

Functions: Component of the protein machinery at the inhibitory synapses, probably acting as a scaffold. Inhibitory synapses dampen neuronal activity through postsynaptic hyperpolarization. This synaptic inhibition is fundamental for the functioning of the central nervous system, shaping and orchestrating the flow of information through neuronal networks to generate a precise neural code

The "INSYN2A Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about INSYN2A comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets